Producción CientíficaIn this issue of Cancer Biology & Therapy, Bachran et al. analyze the effect of two chimeric toxins (SE and SA2E) consisting of the epidermal growth factor (EGF) and the plant protein toxin saporin towards an oral squamous cell carcinoma cell line (BHY) as well as on primary oral squamous cell carcinoma (OSCC) tumour cells
Targeted toxins represent a new approach to specific cytocidal therapy. The ribonucleolytic protein ...
Many epithelial cancers rely on enhanced expression of the epidermal growth factor receptor (EGFR) t...
PURPOSE: Neuroblastomas frequently show expression of the epidermal growth factor receptor (EGFR) an...
Felix Oh,1 Deborah Todhunter,1 Elizabeth Taras,1 Daniel A Vallera,1,2 Antonella Borgatti2,3 1Departm...
Epidermal Growth Factor Receptor (EGFR) has central role in cancer therapy because it causes tumour ...
University of Minnesota M.S. thesis. September 2010. Major: Clinical Laboratory Science. Advisor: Dr...
OBJECTIVE: Oral squamous cell carcinoma (OSCC) is the sixth most common human neoplasm worldwide. Ep...
The epidermal growth factor receptor (EGFR) drives tumor growth in a subset of human epithelial carc...
The current definition of cancer is the creation of atypical cells capable to rapidly grow beyond th...
Immunotoxins (ITs), which are toxin-fused tumor antigen-specific antibody chimeric proteins, have be...
AbstractTargeted toxins represent a new approach to specific cytocidal therapy. The ribonucleolytic ...
Oral squamous cell carcinomas (OSCCs) are characterized by a marked propensity for local invasion an...
We have recently synthesized a peptide called Disruptin, which comprised the SVDNPHVC segment of the...
Molecular targeting strategies for cancer therapy are distinct from conventional chemotherapy and ra...
The epidermal growth factor receptor (EGFR) is now recog-nized as an important target for therapeuti...
Targeted toxins represent a new approach to specific cytocidal therapy. The ribonucleolytic protein ...
Many epithelial cancers rely on enhanced expression of the epidermal growth factor receptor (EGFR) t...
PURPOSE: Neuroblastomas frequently show expression of the epidermal growth factor receptor (EGFR) an...
Felix Oh,1 Deborah Todhunter,1 Elizabeth Taras,1 Daniel A Vallera,1,2 Antonella Borgatti2,3 1Departm...
Epidermal Growth Factor Receptor (EGFR) has central role in cancer therapy because it causes tumour ...
University of Minnesota M.S. thesis. September 2010. Major: Clinical Laboratory Science. Advisor: Dr...
OBJECTIVE: Oral squamous cell carcinoma (OSCC) is the sixth most common human neoplasm worldwide. Ep...
The epidermal growth factor receptor (EGFR) drives tumor growth in a subset of human epithelial carc...
The current definition of cancer is the creation of atypical cells capable to rapidly grow beyond th...
Immunotoxins (ITs), which are toxin-fused tumor antigen-specific antibody chimeric proteins, have be...
AbstractTargeted toxins represent a new approach to specific cytocidal therapy. The ribonucleolytic ...
Oral squamous cell carcinomas (OSCCs) are characterized by a marked propensity for local invasion an...
We have recently synthesized a peptide called Disruptin, which comprised the SVDNPHVC segment of the...
Molecular targeting strategies for cancer therapy are distinct from conventional chemotherapy and ra...
The epidermal growth factor receptor (EGFR) is now recog-nized as an important target for therapeuti...
Targeted toxins represent a new approach to specific cytocidal therapy. The ribonucleolytic protein ...
Many epithelial cancers rely on enhanced expression of the epidermal growth factor receptor (EGFR) t...
PURPOSE: Neuroblastomas frequently show expression of the epidermal growth factor receptor (EGFR) an...